Characteristics and challenges of the clinical pipeline of digital therapeutics

In this Comment, we characterize the current pipeline of digital therapeutics and offer a clinical perspective into the advantages, challenges, and barriers to implementation of this treatment modality for patient care, which we hope will inform future regulatory policy, prescribing decisions, and scope of real-world evidence collection.

Preparing paper insights from the available abstract and paper details.

Authors

Nisarg Patel; Atul J. Butte

Published

Dec 11, 2020

Journal or venue

npj Digital Medicine

DOI

10.1038/s41746-020-00370-8

Paper type

journal article

Source

Openalex